Braftovi Encorafenib — Carefirst Caremark
4 indications indexed for this drug.
- Braf V600 Mutation Positive GliomaView coverage criteria
- Braf V600e Mutation Positive Recurrent Advanced Or MetastatiView coverage criteria
- Cutaneous Melanoma With Braf V600 Mutation Positive AdjuvantView coverage criteria
- Metastatic Or Advanced Colorectal Cancer Including AppendiceView coverage criteria